A. Benson

发表

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

S. Kakar, A. Carrato, A. N. Bartley, 2016, American journal of clinical pathology.

S. Kakar, A. Carrato, A. N. Bartley, 2016, Archives of pathology & laboratory medicine.

S. Kakar, A. Carrato, A. N. Bartley, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.

S. Edge, A. Giuliano, L. Newman, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

J. Blay, M. Sydes, A. Benson, 2015, European journal of cancer.

Radioembolization of colorectal hepatic metastases using yttrium‐90 microspheres

A. Benson, M. Talamonti, M. Mulcahy, 2009, Cancer.

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Charles R. Thomas, A. Benson, J. Ajani, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning

A. Benson, A. Eresen, Zhuoli Zhang, 2020, Journal of Cancer Research and Clinical Oncology.

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation

C. Ulrich, A. Benson, H. Lenz, 2015, Clinical Cancer Research.

Predicting response to EGFR inhibitors in metastatic colorectal cancer: current practice and future directions.

A. Benson, J. Obel, Al B Benson, 2010, The oncologist.

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.

Charles R. Thomas, A. Benson, J. Ajani, 2013, International journal of radiation oncology, biology, physics.

Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis

A. Benson, J. Linder, S. Khan, 2020, Research and practice in thrombosis and haemostasis.

Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

J. Niland, A. Benson, M. Weiser, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rectal Cancer

M. Choti, A. Benson, C. Willett, 2018, Springer International Publishing.

Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

A. Benson, S. Nag, C. Nutting, 2007, International journal of radiation oncology, biology, physics.

Treatment of unresectable cholangiocarcinoma using yttrium‐90 microspheres

A. Benson, M. Mulcahy, R. Omary, 2008, Cancer.

Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.

A. Benson, M. Mulcahy, T. Baker, 2013, Journal of vascular and interventional radiology : JVIR.

Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2018, JNCI cancer spectrum.

Piloting a Financial Counseling Intervention for Patients With Cancer Receiving Chemotherapy.

A. Benson, M. Mulcahy, S. Garcia, 2019, Journal of oncology practice.

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Small Bowel Adenocarcinoma, Version 1.2020

J. Meyerhardt, A. Benson, C. Willett, 2019 .

Refining docetaxel-containing therapy for gastric cancer.

A. Benson, J. Ajani, M. Mulcahy, 2011, Gastrointestinal cancer research : GCR.

Update in Gastrointestinal Cancer Therapeutics

A. Benson, H. Nimeiri, V. Sahai, 2012 .

Cancer of the rectum

A. Benson, B. Minsky, E. Sigurdson, 1960 .

New agents for colorectal cancer.

A. Benson, M. Mulcahy, 2003, Journal of the National Comprehensive Cancer Network : JNCCN.

Chemotherapy: Adding oxaliplatin to the equation

A. Benson, 2009, Nature Reviews Clinical Oncology.

Adjuvant Therapy for Node-Positive Colon Cancer

A. Benson, W. Small, H. Shirazi, 2008 .

The hope for today--the promise for tomorrow: will oncologists meet the challenge?

A. Benson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers

J. Niland, A. Benson, K. Goodman, 2017, Advances in radiation oncology.

Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.

A. Benson, M. Mulcahy, R. Salem, 2014, International journal of radiation oncology, biology, physics.

Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer.

P. Catalano, A. Benson, M. Cornfeld, 2002, Clinical colorectal cancer.

Early‐Stage Colorectal Cancer

A. Benson, V. Sahai, 2014 .

Adjuvant Chemotherapy for Stage II Colon Cancer: Everyone Still Needs a Tailor

A. Benson, M. F. McGee, M. McGee, 2014, Annals of surgical oncology.

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

A. Benson, F. Miller, M. Talamonti, 2008, Radiology.

Management of colorectal cancer during the COVID‐19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative

B. Shogan, A. Benson, M. Mulcahy, 2021, Journal of surgical oncology.

New Approaches toAssessing and Treating Early-Stage Colon and Rectal Cancers: Cooperative Group Strategies forAssessing Optimal Approaches in Early-Stage Disease

A. Benson, 2007 .

The assessment and management of cancer treatment-related diarrhea.

A. Benson, V. Kaklamani, B. O'Brien, 2005, Clinical colorectal cancer.

Eastern Cooperative Oncology Group (E1201) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/ radiotherapy (RT) or irinotecan/cisplatin/RT in esophageal adenocarcinoma: long term outcome and implications for trial design

P. Catalano, A. Benson, L. Kleinberg, 2016 .

Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscape

Benjamin J. Keele, A. Benson, R. Carlos, 2019, Cancer.

Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver.

A. Benson, F. Miller, R. Salem, 2017, Journal of vascular and interventional radiology : JVIR.

Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296).

P. Catalano, A. Benson, F. Spitz, 2012, Gastrointestinal cancer research : GCR.

Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

A. Rademaker, A. Benson, M. Abecassis, 2016, Gastroenterology.

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors.

A. Benson, M. Neary, Jipan Xie, 2017, American health & drug benefits.

Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.

A. Benson, M. Talamonti, R. Joehl, 2001, Surgery.

Neuroendocrine and Adrenal Tumors, Version 2.2021

T. Giordano, A. Benson, M. Soulen, 2021 .

Research reporting standards for radioembolization of hepatic malignancies.

D. Sze, A. Benson, G. Antoch, 2011, Journal of vascular and interventional radiology : JVIR.

Response to treatment series: part 2, tumor response assessment--using new and conventional criteria.

Vahid Yaghmai, A. Benson, F. Miller, 2011, AJR. American journal of roentgenology.

Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

P. Catalano, A. Benson, C. Fuchs, 2002, Journal of the National Cancer Institute.

Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance.

J. Meyerhardt, J. Jeon, A. Benson, 2013, Clinical colorectal cancer.

A rose, is a rose, is a rose...or not.

P. Catalano, A. Benson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort

A. Benson, D. Bentrem, M. Mulcahy, 2022, CardioVascular and Interventional Radiology.

Association of Hospital Procedure Volume and Outcomes in Patients with Colon Cancer at High Risk for Recurrence

J. Meyerhardt, P. Catalano, A. Benson, 2003, Annals of Internal Medicine.

Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of Oncology Advanced Practitioners to Enhance Clinical Research

A. Benson, J. Berenberg, Y. Shvetsov, 2022, Journal of the advanced practitioner in oncology.

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.

A. Benson, F. Miller, M. Mulcahy, 2012, International journal of radiation oncology, biology, physics.

Strong Signature of Natural Selection within an FHIT Intron Implicated in Prostate Cancer Risk

Guillermo E. Rivas, A. Benson, J. Stewart, 2008, PloS one.

Anal Cancer: Emerging Standards in a Rare Rare Disease.

M. Washington, A. Benson, K. Goodman, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is There Efficacy Beyond Cytotoxic Chemotherapy for Pancreatic Cancer?

A. Benson, A. Kalyan, 2016, Journal of oncology practice.

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)

C. Gross, J. Meyerhardt, A. Benson, 2022, The oncologist.

The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance)

J. Meyerhardt, A. Benson, E. Giovannucci, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)

J. Meyerhardt, A. Benson, E. Giovannucci, 2018, Cancer Epidemiology, Biomarkers & Prevention.

Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study.

A. Rademaker, A. Benson, J. Strosberg, 2014, The oncologist.

NCCN practice guidelines for pancreatic cancer.

J. Cameron, A. Benson, C. Willet, 1997, Oncology.

Pilot study of gemcitabine (10 mg/m2 per min) and cisplatin

A. Benson, M. Mulcahy, E. Rubin, 2002, Cancer Chemotherapy and Pharmacology.

Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort

A. Benson, D. Bentrem, M. Mulcahy, 2022, CardioVascular and Interventional Radiology.

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs

A. Benson, Bin Huang, S. Parasramka, 2022, The oncologist.

Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial.

A. Benson, J. Galon, R. Goldberg, 2022, JCO precision oncology.

TREATMENT OF GASTRIC CANCER FOR SURVIVAL-STRATEGIES IN THE USA AND JAPAN

A. Benson, M. Mulcahy, L. Baddi, 2003 .

Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma

A. Benson, D. Bentrem, M. D'Angelica, 2022, Journal of surgical oncology.

Treatment of Metastatic Colorectal Cancer: ASCO Guideline

A. Benson, A. Cercek, M. Fakih, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).

A. Benson, B. Miedema, S. Hamilton, 2022, Annals of surgical oncology.

A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161

S. Libutti, A. Benson, L. Rajdev, 2022, Investigational New Drugs.

Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)

J. Meyerhardt, A. Benson, M. Bertagnolli, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

A Framework for Harmonization of Radiomics Data for Multicenter Studies and Clinical Trials.

A. Benson, R. Salem, V. Yaghmai, 2022, JCO clinical cancer informatics.

Results of the phase Ib study of ipilimumab and gemcitabine for advanced pancreas cancer.

A. Rademaker, A. Benson, M. Mulcahy, 2015 .

Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.

A. Benson, D. Ganger, F. Miller, 2013, Journal of hepatology.

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2018, PloS one.

Impact of diabetes mellitus on outcomes in patients with colon cancer.

J. Meyerhardt, P. Catalano, A. Benson, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kazuhiro Yoshida, A. Benson, Y. Bang, 2018, The Lancet.

Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival.

A. Benson, M. Abecassis, F. Miller, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Charles R. Thomas, A. Benson, J. Ajani, 2008, JAMA.

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.

David Smith, Rebecca Sutphen, John J Rossi, 2009, Cancer research.

Molecular markers in prognosis of colorectal cancer and prediction of response to treatment.

A. Benson, B. Pasche, M. Mulcahy, 2002, Best practice & research. Clinical gastroenterology.

Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2012, Journal of the National Cancer Institute.

Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT.

Guillermo E. Rivas, R. Elston, D. Neuberg, 2005, Cancer research.

MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma

A. Benson, A. Eresen, Zhuoli Zhang, 2020, Journal of Translational Medicine.

Sphincter-Sparing Treatment for Distal Rectal Adenocarcinoma

A. Benson, J. Tepper, R. Mayer, 1999, Annals of Surgical Oncology.

Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients

A. Benson, M. Mulcahy, S. Krantz, 2011, Expert review of anticancer therapy.

Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.

J. Meyerhardt, A. Benson, C. Willett, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)

J. Meyerhardt, A. Benson, E. Giovannucci, 2018, Cancer Epidemiology, Biomarkers & Prevention.

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

D. Spiegelman, J. Meyerhardt, A. Benson, 2013, Journal of the National Cancer Institute.

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

D. Spiegelman, J. Meyerhardt, A. Benson, 2011, Clinical Cancer Research.

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405

J. Meyerhardt, A. Benson, C. Fuchs, 2020, JNCI cancer spectrum.

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

A. Benson, M. Abecassis, F. Miller, 2011, Gastroenterology.

Inoperable pancreatic cancer: standard of care.

A. Benson, W. Small, K. Wisinski, 2007, Oncology.

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors

A. Benson, J. Kirkwood, J. Sparano, 2012, Cancer treatment reviews.

Adjuvant chemotherapy after neoadjuvant chemoradiation and surgery: A quest to improve survival for stage II and III rectal cancer

A. Benson, H. Nimeiri, M. Vergo, 2009 .

Association between DNA Methylation and Shortened Survival in Patients with Advanced Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy

P. Catalano, A. Benson, J. Issa, 2007, Clinical Cancer Research.

HER 2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma Guideline

S. Kakar, A. Carrato, M. Washington, 2016 .

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

A. Benson, E. Van Cutsem, R. Diasio, 2007, The oncologist.

Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy

A. Degramont, R. Labianca, D. Sargent, 2013, Cancer.

Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study.

P. Catalano, A. Benson, J. Luketich, 2015, Annals of surgery.

Bevacizumab in the treatment of colorectal cancer

A. Benson, M. Mulcahy, J. Cilley, 2005, Expert opinion on biological therapy.

The Role of Molecular Markers in Predicting Response to Therapy in Patients with Colorectal Cancer

A. Benson, M. Mulcahy, K. Wisinski, 2012, Molecular Diagnosis & Therapy.

Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.

J. Meyerhardt, A. Benson, M. Bertagnolli, 2011, Journal of the National Cancer Institute.

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

J. Meyerhardt, A. Benson, M. Bertagnolli, 2009, Clinical Cancer Research.

MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials.

M. Bonetti, A. Benson, G. Sledge, 2004, European journal of cancer.

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer

Charles R. Thomas, A. Benson, J. Ajani, 2010, Cancer.

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.

A. Benson, J. Ajani, C. Willett, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstracts reprinted from Journal of Clinical Oncology

S. Lipsitz, A. Benson, E. Guadagnoli, 2002, Annals of Surgical Oncology.

Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling

A. Benson, S. Behr, C. Onodera, 2021, Liver Cancer.

Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinoma

A. Benson, A. Barbault, B. Pasche, 2021, 4open.

Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer models.

A. Benson, W. Xing, Zhuoli Zhang, 2019, American journal of cancer research.

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.

A. Benson, M. Abecassis, F. Miller, 2010, Gastroenterology.

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

J. Meyerhardt, A. Benson, C. Willett, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

A. Benson, F. Miller, E. Wang, 2010, Radiology.

Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy

A. Benson, M. Mulcahy, R. Salem, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

T. Giordano, A. Benson, M. Soulen, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma

J. Meyerhardt, P. Catalano, A. Benson, 2003, Cancer.

90Y Radioembolization for Metastatic Neuroendocrine Liver Tumors: Preliminary Results From a Multi-institutional Experience

A. Benson, M. Mulcahy, R. Omary, 2008, Annals of surgery.

Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial

J. Meyerhardt, A. Benson, E. Giovannucci, 2018, JAMA oncology.

Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation.

P. Catalano, A. Benson, N. Petrelli, 2016 .

Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.

A. Benson, M. Abecassis, F. Miller, 2012, Journal of hepatology.

Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.

A. Benson, M. Abecassis, F. Miller, 2011, Gastroenterology.

Point: Treating stage II colon cancer: the quest for personalized adjuvant care.

A. Benson, M. Vergo, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Prognostic and Predictive Markers in Colorectal Cancer

A. Benson, S. Reddy, M. Vergo, 2011 .

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience

A. Benson, M. Abecassis, D. Ganger, 2018, Hepatology.

The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.

A. Benson, C. Willett, T. Showalter, 2011, International journal of radiation oncology, biology, physics.

Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement.

J. Meyerhardt, A. Benson, N. Petrelli, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality

A. Benson, K. Bilimoria, D. Winchester, 2016, Annals of surgery.

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

P. Catalano, A. Benson, T. Longacre, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts.

S. Edge, A. Benson, R. Carlson, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Responsibility for costs associated with clinical trials.

F. M. Stewart, A. Benson, N. Petrelli, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

J. Meyerhardt, A. Benson, E. Giovannucci, 2015, Journal of the National Cancer Institute.

Anal Carcinoma , Version 2 . 2018 Clinical Practice Guidelines in Oncology

J. Meyerhardt, A. Benson, James D. Murphy, 2018 .

First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA

A. Benson, M. Broder, A. Benson, 2018, Journal of medical economics.

Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2014, PloS one.

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

A. Benson, J. Galon, R. Goldberg, 2020, JNCI Cancer Spectrum.

Impact of smoking on patients with stage III colon cancer

J. Meyerhardt, A. Benson, R. Goldberg, 2010, Cancer.

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set.

Brian Bot, Greg Yothers, Qian Shi, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors

E. Nakakura, M. Choti, A. Benson, 2021, Pancreas.

Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)

C. Gross, J. Meyerhardt, A. Benson, 2021, JNCI cancer spectrum.

Recommendations for the Role of Clinical Pathways in an Era of Personalized Medicine

A. Benson, C. Balch, R. Rifkin, 2016 .

Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study

A. Benson, D. Cella, M. Mulcahy, 2014, Supportive Care in Cancer.

Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization.

A. Benson, M. Abecassis, D. Cella, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Pre- and postoperative adjuvant therapy for locally advanced rectal cancer.

A. Benson, M. Mulcahy, L. McGartland, 2004, Clinical advances in hematology & oncology : H&O.

A. Benson, Y. Bang, C. Fuchs, 2021, Gastric Cancer.

Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot study

A. Benson, A. Eresen, Zhuoli Zhang, 2020, Cancer Imaging.

Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.

A. Benson, M. Abecassis, F. Miller, 2010, JAMA.

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

A. Benson, M. Abecassis, M. Mulcahy, 2007, Hepatology.

Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, A. Benson, C. Willett, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Colon Cancer , Version 3 . 2014 Clinical Practice Guidelines in Oncology

A. Benson, James D. Murphy, C. Willett, 2014 .

Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

W. Willett, F. Hu, J. Meyerhardt, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy for stage II colon cancer: prognostic and predictive markers.

A. Benson, B. Vicuna, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Risk assessment and adjuvant systemic therapy in resected stage II colon cancer

A. Benson, V. Shankaran, P. Khrizman, 2009 .

A multidisciplinary approach to the management of hepatocellular carcinoma.

A. Benson, J. Marrero, R. Gish, 2010, Gastroenterology & hepatology.

Hepatobiliary Cancers Clinical Practice Guidelines in OncologyTM

S. Curley, A. Benson, J. Marrero, 2009 .

Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study.

A. Benson, C. Bennett, E. Tarlov, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in—A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

C. Gatsonis, P. Catalano, A. Benson, 2021 .

Impact of diabetes and insulin use on prognosis in patients with resected pancreatic cancer: an ancillary analysis of NRG Oncology RTOG 9704.

R. Abrams, A. Benson, C. Fuchs, 2020, International journal of radiation oncology, biology, physics.

90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study

A. Benson, J. Geschwind, S. Kwan, 2016, The Journal of Nuclear Medicine.

Adjuvant therapy for Colon Cancer

A. Benson, O. Aranha, 2007, Current gastroenterology reports.

Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2018, Journal of the National Cancer Institute.

Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.

A. Benson, M. Abecassis, M. Mulcahy, 2011, International journal of radiation oncology, biology, physics.

Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: Analyzing patterns of progression in 285 patients

A. Benson, M. Abecassis, F. Miller, 2012, Hepatology.

Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation.

A. Benson, M. Abecassis, F. Miller, 2011, Journal of hepatology.

Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival.

A. Benson, M. Mulcahy, R. Omary, 2010, Journal of vascular and interventional radiology : JVIR.

Impact o f D iabetes M ellitus o n O utcomes i n P atients W ith Colon C ancer

J. Meyerhardt, P. Catalano, A. Benson, 2003 .

Treatment Trends and Predictors of Adjuvant and Neoadjuvant Therapy for Gastric Adenocarcinoma in the United States

A. Benson, D. Bentrem, K. Bilimoria, 2013, Annals of Surgical Oncology.

Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation

A. Benson, M. Abecassis, D. Ganger, 2019, CardioVascular and Interventional Radiology.

Right atrial Merkel cell carcinoma metastasis.

A. Benson, C. Farrelly, A. Keeling, 2010, Journal of the American College of Cardiology.

Pathological Complete Response After Neoadjuvant Therapy for Rectal Cancer and the Role of Adjuvant Therapy

A. Benson, Valerie M Nelson, 2013, Current Oncology Reports.

MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma

A. Benson, A. Eresen, Zhuoli Zhang, 2020, Journal of Translational Medicine.

Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study.

A. Benson, J. Geschwind, M. Mulcahy, 2013, European journal of cancer.

Internal radioembolization for colorectal carcinoma liver metastases

A. Benson, M. Mulcahy, R. Salem, 2009 .

43 : Intergroup RTOG 9811 Phase III Comparison Of Chemoradiation With 5-FU and Mitomycin Vs 5-FU and Cisplatin for Anal Canal Carcinoma: Impact on Disease-Free, Overall and Colostomy-Free Survival

Charles R. Thomas, A. Benson, J. Ajani, 2006 .

The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settings.

A. Benson, L. Dawson, W. Small, 2010, Clinical colorectal cancer.

New approaches to the adjuvant therapy of colon cancer.

A. Benson, 2006, The oncologist.

Diet- and Lifestyle‐Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance)

D. Spiegelman, C. Gross, J. Meyerhardt, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI Radiomics: A Preliminary Investigation.

A. Benson, A. Eresen, Zhuoli Zhang, 2020, Academic radiology.

Reply to C.C. Earle.

J. Meyerhardt, A. Benson, P. Mangu, 2014, Journal of Clinical Oncology.

A Phase II Trial of Weekly Gemcitabine and Bevacizumab in Combination with Abdominal Radiation Therapy in Patients with Localized Pancreatic Cancer

A. Rademaker, A. Benson, D. Bentrem, 2007 .

Medicine as it should be: a cultural shift.

A. Benson, 2011, Journal of Oncology Practice.

A multidisciplinary approach to the management of hepatocellular carcinoma.

A. Benson, J. Marrero, R. Gish, 2010, Gastroenterology & hepatology.

Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer

J. Meyerhardt, A. Benson, E. Giovannucci, 2022, JAMA network open.

90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study

A. Benson, J. Geschwind, S. Kwan, 2016, The Journal of Nuclear Medicine.

Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.

A. Benson, M. Abecassis, F. Miller, 2010, JAMA.

Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting response to EGFR inhibitors in metastatic colorectal cancer: current practice and future directions.

A. Benson, J. Obel, V. Shankaran, 2010, The oncologist.

Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.

A. Benson, M. Abecassis, F. Miller, 2011, Gastroenterology.

Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2012, Journal of the National Cancer Institute.

Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

J. Niland, A. Benson, M. Weiser, 2013, Journal of Clinical Oncology.

Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer: ECOG 3204

A. Benson, E. Sigurdson, R. Whittington, 2009 .

Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non–Safety-Net Centers

A. Benson, W. Gradishar, B. Rapkin, 2021, JCO oncology practice.

Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver.

A. Benson, F. Miller, R. Salem, 2017, Journal of vascular and interventional radiology : JVIR.

Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients

A. Benson, M. Mulcahy, S. Krantz, 2011, Expert review of anticancer therapy.

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2018, PloS one.

Adjuvant therapy for stage II colon cancer: prognostic and predictive markers.

A. Benson, B. Vicuna, 2007, The Journal of the National Comprehensive Cancer Network.